Pharma

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Medtronic, Inc. announced at its annual institutional investor and analyst meeting that the company purchased substantially all glucose monitoring assets from PreciSense A/S, a Denmark-based development company focused on continuous glucose monitoring technology. Specific terms of the acquisition were not disclosed.

Today in Medical Devices/Products...keeping you current

New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists
Amgen, 12/04/09

Genzyme Begins Shipping Newly Produced Cerezyme from Allston Plant
Genzyme, 12/02/09

Bayer's Betaferon approved in China for Treatment of Multiple Sclerosis
BayNews International, 12/02/09